(Q34177532)
Statements
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy (English)
Mary Beth Beasley
Vicki Leigh Keedy
Sarah Temin
Mark R Somerfield
David H Johnson
Lisa M McShane
Daniel T Milton
John R Strawn
Heather A Wakelee